Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures

Journal of Allergy and Clinical Immunology

Volumn 141, Issue 6, 2018, Pages 2074-2084

  Essaidi Laziosi, Manel ^a   Brito, Francisco ^a   Benaoudia, Sacha ^b   Royston, Léna ^a   Cagno, Valeria ^a   Fernandes Rocha, Mélanie ^c   Piuz, Isabelle ^a   Zdobnov, Evgeny ^a   Huang, Song ^b   Constant, Samuel ^b   Boldi, Marc Olivier ^d   Kaiser, Laurent ^c   Tapparel, Caroline ^a,c  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Epithelix   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

cytokines; cytotoxicity; immune response; mucociliary clearance; pathogenesis; persistence; Respiratory virus; rhinovirus

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENOMIC RNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 25; INTERLEUKIN 29; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; PROTEIN VP2; RANTES; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS RNA;

ADULT; AGED; ARTICLE; BASAL CELL; CELL DEATH; CHILD; CILIATED EPITHELIUM CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENTEROVIRUS D68; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN CORONAVIRUS OC43; HUMAN TISSUE; IMMUNE RESPONSE; INFANT; INFLUENZA A VIRUS (H3N2); INNATE IMMUNITY; MUCOCILIARY CLEARANCE; NEWBORN; PERSISTENT VIRUS INFECTION; PNEUMOVIRUS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS B; RESPIRATORY VIRUS; RHINOVIRUS; RHINOVIRUS A49; RHINOVIRUS A55; RHINOVIRUS B48; RHINOVIRUS C15; RHINOVIRUS C8; RNA SEQUENCE; TISSUE METABOLISM; VIRAL RESPIRATORY TRACT INFECTION; VIRAL TROPISM; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; PATHOPHYSIOLOGY; RESPIRATORY MUCOSA; RNA VIRUS; RNA VIRUS INFECTION; VIROLOGY;

HUMANS; RESPIRATORY MUCOSA; RNA VIRUS INFECTIONS; RNA VIRUSES;

EID: 85028884957     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.07.018     Document Type: Article

References (58)

1. World Health Organization. Global Health Observatory (GHO) data—child mortality and causes of death 2015. Available at: http://www.who.int/gho/child_health/mortality/causes/en/. Accessed December 2016.
2. Denny, F.W. Jr., The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 152:suppl (1995), S4–S12.
3. Ambrosioni, J., Bridevaux, P.O., Wagner, G., Mamin, A., Kaiser, L., Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011-2012. Clin Microbiol Infect 20 (2014), O578–O584.
4. Tregoning, J.S., Schwarze, J., Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 23 (2010), 74–98.
5. Khan, F., Enterovirus D68: acute respiratory illness and the 2014 outbreak. Emerg Med Clin North Am 33 (2015), e19–32.
6. Bertino, J.S., Cost burden of viral respiratory infections: issues for formulary decision makers. Am J Med 112:suppl 6A (2002), 42S–49S.
7. Nguyen, C., Kaku, S., Tutera, D., Kuschner, W.G., Barr, J., Viral respiratory infections of adults in the intensive care unit. J Intensive Care Med 31 (2016), 427–441.
8. Stokes, K.L., Chi, M.H., Sakamoto, K., Newcomb, D.C., Currier, M.G., Huckabee, M.M., et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol 85 (2011), 5782–5793.
9. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14 (2008), 199–204.
10. Margine, I., Krammer, F., Animal models for influenza viruses: implications for universal vaccine development. Pathogens 3 (2014), 845–874.
11. Bochkov, Y.A., Watters, K., Basnet, S., Sijapati, S., Hill, M., Palmenberg, A.C., et al. Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells. Virology 499 (2016), 350–360.
12. Villenave, R., Shields, M.D., Power, U.F., Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol 21 (2013), 238–244.
13. Mitchell, H., Levin, D., Forrest, S., Beauchemin, C.A., Tipper, J., Knight, J., et al. Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling. J Virol 85 (2011), 1125–1135.
14. Bochkov, Y.A., Palmenberg, A.C., Lee, W.M., Rathe, J.A., Amineva, S.P., Sun, X., et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med 17 (2011), 627–632.
15. Hao, W., Bernard, K., Patel, N., Ulbrandt, N., Feng, H., Svabek, C., et al. Infection and propagation of human rhinovirus C in human airway epithelial cells. J Virol 86 (2012), 13524–13532.
16. Tapparel, C., Sobo, K., Constant, S., Huang, S., Van Belle, S., Kaiser, L., Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro. Virology 446 (2013), 1–8.
17. Knight, D.A., Holgate, S.T., The airway epithelium: structural and functional properties in health and disease. Respirology 8 (2003), 432–446.
18. Roche, W.R., Montefort, S., Baker, J., Holgate, S.T., Cell adhesion molecules and the bronchial epithelium. Am Rev Respir Dis 148:suppl (1993), S79–S82.
19. Smith, D.J., Gaffney, E.A., Blake, J.R., Modelling mucociliary clearance. Respir Physiol Neurobiol 163 (2008), 178–188.
20. Nakagome, K., Bochkov, Y.A., Ashraf, S., Brockman-Schneider, R.A., Evans, M.D., Pasic, T.R., et al. Effects of rhinovirus species on viral replication and cytokine production. J Allergy Clin Immunol 134 (2014), 332–341.
21. Hothorn, T., Bretz, F., Westfall, P., Simultaneous inference in general parametric models. Biom J 50 (2008), 346–363.
22. Peng, Y., Leung, H.C., Yiu, S.M., Chin, F.Y., IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth. Bioinformatics 28 (2012), 1420–1428.
23. Wilm, A., Aw, P.P., Bertrand, D., Yeo, G.H., Ong, S.H., Wong, C.H., et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 40 (2012), 11189–11201.
24. Wei, Z., Wang, W., Hu, P., Lyon, G.J., Hakonarson, H., SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data. Nucleic Acids Res, 39, 2011, e132.
25. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25 (2009), 2078–2079.
26. Lupo, J., Schuffenecker, I., Morel-Baccard, C., Bardet, J., Payen, V., Kaiser, L., et al. Disseminated rhinovirus C8 infection with infectious virus in blood and fatal outcome in a child with repeated episodes of bronchiolitis. J Clin Microbiol 53 (2015), 1775–1777.
27. Tapparel, C., Cordey, S., Junier, T., Farinelli, L., Van Belle, S., Soccal, P.M., et al. Rhinovirus genome variation during chronic upper and lower respiratory tract infections. PLoS One, 6, 2011, e21163.
28. Essaidi-Laziosi, M., Lyon, M., Mamin, A., Fernandes Rocha M, Kaiser L, Tapparel C. A new real-time RT-qPCR assay for the detection, subtyping and quantification of human respiratory syncytial viruses positive- and negative-sense RNAs. J Virol Methods 235 (2016), 9–14.
29. L'Huillier, A.G., Kaiser, L., Petty, T.J., Kilowoko, M., Kyungu, E., Hongoa, P., et al. Molecular epidemiology of human rhinoviruses and enteroviruses highlights their diversity in Sub-Saharan Africa. Viruses 7 (2015), 6412–6423.
30. Borg, I., Rohde, G., Loseke, S., Bittscheidt, J., Schultze-Werninghaus, G., Stephan, V., et al. Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J 21 (2003), 944–951.
31. Esposito, S., Daleno, C., Scala, A., Castellazzi, L., Terranova, L., Sferrazza Papa, S., et al. Impact of rhinovirus nasopharyngeal viral load and viremia on severity of respiratory infections in children. Eur J Clin Microbiol Infect Dis 33 (2014), 41–48.
32. Ngaosuwankul, N., Noisumdaeng, P., Komolsiri, P., Pooruk, P., Chokephaibulkit, K., Chotpitayasunondh, T., et al. Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J, 7, 2010, 75.
33. Zhang, L., Peeples, M.E., Boucher, R.C., Collins, P.L., Pickles, R.J., Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 76 (2002), 5654–5666.
34. Reed, S.E., Persistent respiratory virus infection in tracheal organ cultures. Br J Exp Pathol 50 (1969), 378–388.
35. Jakiela, B., Gielicz, A., Plutecka, H., Hubalewska-Mazgaj, M., Mastalerz, L., Bochenek, G., et al. Th2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection. Am J Respir Cell Mol Biol 51 (2014), 229–241.
36. Griggs, T.F., Bochkov, Y.A., Basnet, S., Pasic, T.R., Brockman-Schneider, R.A., Palmenberg, A.C., et al. Rhinovirus C targets ciliated airway epithelial cells. Respir Res, 18, 2017, 84.
37. Dijkman, R., Jebbink, M.F., Koekkoek, S.M., Deijs, M., Jonsdottir, H.R., Molenkamp, R., et al. Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol 87 (2013), 6081–6090.
38. Ibricevic, A., Pekosz, A., Walter, M.J., Newby, C., Battaile, J.T., Brown, E.G., et al. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80 (2006), 7469–7480.
39. Persson, B.D., Jaffe, A.B., Fearns, R., Danahay, H., Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLoS One, 9, 2014, e102368.
40. Kindler, E., Gil-Cruz, C., Spanier, J., Li, Y., Wilhelm, J., Rabouw, H.H., et al. Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog, 13, 2017, e1006195.
41. Wang, G., Deering, C., Macke, M., Shao, J., Burns, R., Blau, D.M., et al. Human coronavirus 229E infects polarized airway epithelia from the apical surface. J Virol 74 (2000), 9234–9239.
42. Smith, C.M., Kulkarni, H., Radhakrishnan, P., Rutman, A., Bankart, M.J., Williams, G., et al. Ciliary dyskinesia is an early feature of respiratory syncytial virus infection. Eur Respir J 43 (2014), 485–496.
43. Arruda, E., Boyle, T.R., Winther, B., Pevear, D.C., Gwaltney, J.M. Jr., Hayden, F.G., Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis 171 (1995), 1329–1333.
44. Winther, B., Effects on the nasal mucosa of upper respiratory viruses (common cold). Dan Med Bull 41 (1994), 193–204.
45. Hendley, J.O., Clinical virology of rhinoviruses. Adv Virus Res 54 (1999), 453–466.
46. Tadokoro, T., Wang, Y., Barak, L.S., Bai, Y., Randell, S.H., Hogan, B.L., IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells. Proc Natl Acad Sci U S A 111 (2014), E3641–E3649.
47. Wu, N.H., Yang, W., Beineke, A., Dijkman, R., Matrosovich, M., Baumgartner, W., et al. The differentiated airway epithelium infected by influenza viruses maintains the barrier function despite a dramatic loss of ciliated cells. Sci Rep, 6, 2016, 39668.
48. Pittet, L.A., Hall-Stoodley, L., Rutkowski, M.R., Harmsen, A.G., Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol 42 (2010), 450–460.
49. Iravani, J., Melville, G.N., Horstmann, G., Tracheobronchial clearance in health and disease: with special reference to interciliary fluid. Ciba Found Symp 54 (1978), 235–252.
50. Wilson, R., Alton, E., Rutman, A., Higgins, P., Al Nakib, W., Geddes, D.M., et al. Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis 70 (1987), 272–279.
51. Catley, M.C., Sukkar, M.B., Chung, K.F., Jaffee, B., Liao, S.M., Coyle, A.J., et al. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol 70 (2006), 697–705.
52. Mazur, I., Wurzer, W.J., Ehrhardt, C., Pleschka, S., Puthavathana, P., Silberzahn, T., et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol 9 (2007), 1683–1694.
53. Kalies, K.U., Romisch, K., Inhibitors of protein translocation across the ER membrane. Traffic 16 (2015), 1027–1038.
54. Heaton, N.S., Moshkina, N., Fenouil, R., Gardner, T.J., Aguirre, S., Shah, P.S., et al. Targeting viral proteostasis limits influenza virus, HIV, and dengue virus infection. Immunity 44 (2016), 46–58.
55. Syedbasha, M., Egli, A., Interferon lambda: modulating immunity in infectious diseases. Front Immunol, 8, 2017, 119.
56. Lembo, D., Cagno, V., Civra, A., Poli, G., Oxysterols: An emerging class of broad spectrum antiviral effectors. Mol Aspects Med 49 (2016), 23–30.
57. Koszalka, P., Tilmanis, D., Hurt, A.C., Influenza antivirals currently in late-phase clinical trial. Influenza Other Respir Viruses 11 (2017), 240–246.
58. Abdelnabi, R., Morais, A.T.S., Leyssen, P., Imbert, I., Beaucourt, S., Blanc, H., et al. Understanding the mechanism of the broad-spectrum antiviral activity of favipiravir (T-705): key role of the F1 motif of the viral polymerase. J Virol, 91(12), 2017.